Optimization of the autophagy measurement in a human cell line and primary cells by flow cytometry
Tonino Alonzi(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani), Delia Goletti(Istituto Nazionale per le Malattie Infettive Lazzaro Spallanzani)
Cited by 11
Related Papers
Baricitinib therapy in COVID-19: A pilot study on safety and clinical impact
|Journal of Infection|2020|445
Beneficial impact of Baricitinib in COVID-19 moderate pneumonia; multicentre study
|Journal of Infection|2020|179